|
Mercado cerrado -
Otros sitios de cotización
|
Variación 5 días | Varia. 1 de enero. | ||
| 2,290 CHF | -1,29 % |
|
+13,37 % | +178,59 % |
| 30/06 | Perspectiva Económica Sombría Pesa Sobre las Acciones Suizas | MT |
| 30/06 | Idorsia Informa Resultados Prometedores en Ensayo de Fase 1 de su Vacuna de Glicano Sintético | MT |
Grupo Idorsia Ltd : Gráfico Relacional
Empresas privadas pertenecientes al mismo grupo que IDORSIA LTD
| Empresa | Director |
|---|---|
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | - |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition